AMIC versus MACI for focal cartilage repairAMIC repairs focal cartilage defects in one operation: drilling channels into damaged cartilage releases a blood clot rich in stem cells, which a collagen membrane then stabilises and concentrates to guide tissue repair. A 2025 trial found it equivalent to MACI at two years.AMIC repairs focal cartilage defects in one operation: drilling channels into damaged cartilage releases a blood clot rich in stem cells, which a collagen membrane then stabilises and concentrates to guide tissue repair. A 2025 trial found it equivalent to MACI at two years.
ChondroFiller success rates in practiceChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.ChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.
Choosing joint preserving surgery before knee replacementOne-compartment knee wear does not automatically mean replacement is next: bracing, osteotomy and focal cartilage repair can reduce pain and delay arthroplasty when alignment and damage remain localised. Microfracture is now usually limited to very small defects, while AMIC, MACI, OATS and OCA are chosen by lesion size, depth and…One-compartment knee wear does not automatically mean replacement is next: bracing, osteotomy and focal cartilage repair can reduce pain and delay arthroplasty when alignment and damage remain localised. Microfracture is now usually limited to very small defects, while AMIC, MACI, OATS and OCA are chosen by lesion size, depth and joint health.
ChondroFiller and cortisone treat different knee problemsCortisone and ChondroFiller treat different knee problems: cortisone is short-term symptom control for diffuse osteoarthritis or an inflammatory flare, with benefit usually measured in weeks to a few months, while ChondroFiller is a single-stage cell-free collagen scaffold designed for clearly localised grade III or IV cartilage defects and selected osteochondral…Cortisone and ChondroFiller treat different knee problems: cortisone is short-term symptom control for diffuse osteoarthritis or an inflammatory flare, with benefit usually measured in weeks to a few months, while ChondroFiller is a single-stage cell-free collagen scaffold designed for clearly localised grade III or IV cartilage defects and selected osteochondral lesions. A broadly worn knee should not assume a focal scaffold will help, and a defined cartilage lesion should not assume a cortison...